AFFICHEM
Desconocido
AFHELO: Preclinical proof of concept of AF243 potency to prevent and or treat sensorineural hearing loss
AFFICHEM SA
tramitó un
FP7:
Approximately 10% of the global population (40% of people over 65), suffers hearing difficulties. The socio-economic impact is deep, since i...
Financiado
Financiado
TARGEAR: Targeting challenges of active ageing innovative integrated strategies for the healing of age relat...
AFFICHEM SA
participó en un
FP7:
"Worldwide, 278 million people are estimated to have moderate to profound hearing loss. Age-related hearing loss, also known as presbyacusis...
Financiado
Financiado
* No se disponen de datos de la empresa actual.